Kiniksa Pharmaceuticals International. (KNSA) Q1 2024 Earnings

23AprConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.25
-0.05
0.15
0.35

Details

Expected EPS
-0.082116
Actual EPS
-0.25
Surprise EPS
-0.17
Surprise Percent
+204.45%

Description

Kiniksa Pharmaceuticals International. (KNSA) has reported earnings of -0.25 per share for Q1 2024.

0 Comments

Share your thoughts